The Egyptian Company for Medical Investments (ECMI) and its subsidiaries, Egyptian Pharmaceutical Trading Company (EPTC) and El Gomhouria Company for Pharmaceuticals, Chemicals and Medical Supplies (GOMCO), ECMI is characterized by the highest competencies and innovative solutions that help distinguished business partners achieve the highest productivity.
On August 11, 2020, the decision of His Excellency the Prime Minister was issued to license the Egyptian Authority for Unified Purchasing, Medical Supply and Supply and Medical Technology Management to establish a joint stock company named "Egyptian Medical Investments Company" in accordance with the provisions of the law of joint stock companies, stock recommendation companies, limited liability companies and single person companies; and its purpose is to engage in the following activities, directly or through one of its companies, as follows:- 1- Transport and distribution of medical preparations procured by the Egyptian Authority for Unified Purchasing. 2- Managing the system of strategic warehouses that the Authority establishes in partnership with state agencies and entities. 3- Maximizing the utilization of the state's strategic stock of pharmaceuticals and medical supplies. 4- Contributing to the implementation of the localization and development plan for the pharmaceuticals and medical supplies industry developed by the Egyptian Authority for Unified Purchasing in conjunction with the concerned authorities. The company was established under Certificate of Incorporation No. 6107 on 3-6-2020
Our vision is to ensure access to top-notch medical services for all, regardless of location, through strategic partnerships, operational optimization, and a relentless focus on customer satisfaction.
Our mission is to enhance healthcare in our communities through innovative technologies and expanded services. We aim to be the top healthcare investment company in Egypt by delivering exceptional value through excellence, growth, and customer-centricity.
ECMI aspires to provide the best consultancy in the Egyptian pharmaceutical market with a focus on growth and efficiency, while developing strategic enablers. The company aims to accelerate the digitization process across sales channels, operations, and e-commerce activation. It also seeks to attract, develop, and retain the best talent, supporting them by providing best-in-class processes and systems.